Drug Profile
Research programme: serotonin 2A receptor antagonists - Eli Lilly and Company
Alternative Names: FMPDLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Benzodiazepines; Small molecules
- Mechanism of Action Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Psychotic-disorders in USA (PO)